February 7, 2018
Authored and Edited by Pier D. DeRoo; Kara A. Specht; Elizabeth D. Ferrill
Petitioner Maxlinear filed two co-pending IPR proceedings against the ’585 patent, each asserting different prior art. In one IPR proceeding, the PTAB invalidated the independent claims, which the Federal Circuit affirmed in CF Crespe LLC v. Silicon Labs. Inc., No. 2017-1072, 2017 WL 6044690 (Fed. Cir. Dec. 7, 2017). But because the IPR did not involve dependent claims 4, 6-9, and 21, those claims remained patentable and available for assertion against Petitioner Maxlinear.
In the other proceeding, the PTAB upheld the instituted claims, but based its decision on the patentability of the independent claims over the asserted prior art, and did not separately discuss or analyze the dependent claims. On appeal, the Federal Circuit concluded that collateral estoppel applied as to the independent claims based on the invalidity holding from the earlier appeal in the co-pending IPR. This estoppel, as the Federal Circuit stated, abrogated the basis of the PTAB’s decision on the dependent claims in the second IPR, because the dependent claims were upheld solely based on the patentability of the now-invalid independent claims. Thus, the court vacated and remanded for the PTAB to re-analyze dependent claims 4, 6-9, and 21.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
May 20, 2026
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
At the PTAB Blog
Revvo‑lution in Discretionary Denial: Claim Construction Consistency Takes Center Stage
April 28, 2026
Articles
Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing
April 24, 2026
Federal Circuit IP Blog
Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim
April 15, 2026
Federal Circuit IP Blog
April 15, 2026
Articles
Prosecution History Estoppel: Navigating Limits on Equivalents in Patent Litigation
March/April 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.